Flores, Crispina F.

HRN: 05-38-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFTRIAXONE 1G (VIAL)
06/24/2025
07/01/2025
IV
2gms
OD
CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines